Union Cabinet, Bio-RIDE and biotechnology
Cabinet Approves 'Bio-RIDE' Scheme to Boost Biotechnology Research and Innovation
The Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the continuation of two umbrella schemes from the Department of Biotechnology (DBT), merging them into a single initiative called the Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE).
Cabinet approves ‘Bio-RIDE’ scheme to support cutting edge research and development in Biotechnology
The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, today approved continuation of the two umbrella schemes of Department of Biotechnology (DBT), merged as one scheme-‘Biotechnology Research Innovation and Entrepreneurship Development (Bio- RIDE)’ with a new component namely Biomanufacturing and Biofoundry.
Minister of Agriculture and Food Security, Senator Abubakar Kyari has underscored the important role of modern biotechnology ...
Kineta will be trading under the symbol “KANT” on OTC PinkKineta will continue to pursue strategic alternatives as previously announcedTuHURA ...
7hon MSN
We recently published a list of 7 Best ASX Stocks To Invest In Right Now. In this article, we are going to take a look at ...
Those who graduate from the facility at Passaic County Technical Institute in Wayne will get associate’s degrees in ...
USA in Columbus, Ohio, in fall 2025, to cover the North American market. The new offshoot of the world's leading trade fair ...
A French biotechnology giant just opened a molecular and genomic innovation center at Philly’s Navy Yard after acquiring a ...
To determine the Best Workplaces in Biotechnology and Pharmaceuticals in 2024, Fortune partnered with global people ...
As the famed British naturalist David Attenborough noted, “In our hands now lies not only our own future but that of all ...
Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $7.8 which represents a decrease of $-0.13 or -1.64% from the prior close of $7.93. The stock opened at $7.94 and touched a low of $7 ...
To determine the Best Workplaces in Biotechnology and Pharmaceuticals in 2024, Fortune partnered with global people analytics firm Great Place to Work to analyze survey feedback representing more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback